No menu items!
Sunday, February 23, 2025

head of molecular oncology

DBT-NII Receives Trademark for India’s First Indigenous Tumour Antigen SPAG9

ASPAGNIITM is being used in dendritic cell (DC) based immunotherapy in cervical, ovarian cancer and will also be used in breast cancer. ASPAGNIITM may revolutionise cancer treatment Cancer kills 8.51 lakh people in India every year (International Agency for Research on...
- Advertisement -spot_img

Latest News

CII Pune Launches Year-Long MSME Training Program

The Confederation of Indian Industry (CII) Pune chapter has announced a series of workshops across western Maharashtra to support...
- Advertisement -spot_img